1126. Effect of Remdesivir on Recovery, Quality of Life, and Long-COVID Symptoms One Year after Hospitalization for COVID-19 Infection: A Randomized Controlled SOLIDARITY Finland Trial

BACKGROUND: Coronavirus disease 2019 (COVID-19) patients frequently suffer from long-term sequelae, often called “long COVID” or “post COVID-19 condition”. Remdesivir, given in early disease, decreases the risk of hospitalization and potentially mortality. No randomized trials have thus far publishe...

Descripción completa

Detalles Bibliográficos
Autores principales: Nevalainen, Olli P O, Horstia, Saana, Laakkonen, Sanna, Rutanen, Jarno, Mustonen, Jussi, Kalliala, Ilkka, Ansakorpi, Hanna, Kreivi, Hanna-Riikka, Kuutti, Pauliina, Paajanen, Juuso, Parkkila, Seppo, Paukkeri, Erja-Leena, Perola, Markus, Pourjamal, Negar, Renner, Andreas, Rosberg, Tuomas, Rutanen, Taija, Savolainen, Joni, Haukka, Jari K, Guyatt, Gordon H, Tikkinen, Kari A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752133/
http://dx.doi.org/10.1093/ofid/ofac492.965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752133/
http://dx.doi.org/10.1093/ofid/ofac492.965

Ejemplares similares